motixafortide 62 MG Injection [Aphexda]

RxCUI: 2664906
RxNorm name: motixafortide 62 MG Injection [Aphexda]
Display name: motixafortide 62 MG Injection [Aphexda]
Full name: motixafortide 62 MG Injection [Aphexda]
Term type: SBD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:25

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
APHEXDA	MOTIXAFORTIDE	Gamida Cell Inc.	e704b2db-f119-40ba-9346-9229e3281c9e	2026-06-04	Warnings, Adverse reactions	Exact identifier rxcui: 2664906
Aphexda	MOTIXAFORTIDE	BioLineRx USA Inc	f7cdc584-ebf0-a68e-e053-6294a90a9ea9	2024-10-10	Warnings, Adverse reactions	Exact identifier rxcui: 2664906

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
e704b2db-f119-40ba-9346-9229e3281c9e	APHEXDA 62 MG Injection [PSN] · motixafortide 62 MG Injection [Aphexda] [SBD] · Aphexda 62 MG (as motixafortide acetate) Injection [SY] · Aphexda 62 MG Injection [SY]	4	4	These highlights do not include all the information needed to use APHEXDA safely and effectively. See full prescribing information for APHEXDA. APHEXDA ® (motixafortide) for injection, for subcutaneous use Initial U.S. Approval: 2023	20251028
f7cdc584-ebf0-a68e-e053-6294a90a9ea9	APHEXDA 62 MG Injection [PSN] · motixafortide 62 MG Injection [Aphexda] [SBD] · Aphexda 62 MG (as motixafortide acetate) Injection [SY] · Aphexda 62 MG Injection [SY]	4	2	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use APHEXDA safely and effectively. See full prescribing information for APHEXDA. APHEXDA TM (motixafortide) for injection, for subcutaneous use. Initial U.S. Approval: 2023	20241010